Furthermore, we found a positive correlation between these six genes and the genes encoding APP and MAPT, suggesting that FUNDC1, MAP1LC3A, CSNK2A1, VDAC1, CSNK2B, and ATG5 have the potential to be used as reliable biomarkers to successfully establish AD diagnosis. The gene discussed is MAPT; the disease is Alzheimer disease.